Choline alfoscerate
- Generic Name
- Choline alfoscerate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H20NO6P
- CAS Number
- 28319-77-9
- Unique Ingredient Identifier
- 60M22SGW66
- Background
A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. [PubChem]
- Associated Conditions
- Affective Disorders, Cognitive Dysfunctions, Dementia, Multi-Infarct, Stroke, Traumatic Brain Injury (TBI)
- Associated Therapies
- -
Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints
- Conditions
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2022-02-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT05257902
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
- Conditions
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 418
- Registration Number
- NCT05041790
- Locations
- 🇰🇷
Asan Medical Center Institutional Review Board, Seoul, Korea, Republic of
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
- Conditions
- Interventions
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT03249259
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment
- Conditions
- Interventions
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Target Recruit Count
- 62
- Registration Number
- NCT03228498
- Locations
- 🇮🇹
Stroke Unit, VAS-COG clinic, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 128
- Registration Number
- NCT02648906
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Sungnam, Korea, Republic of
The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
- Conditions
- Interventions
- First Posted Date
- 2011-06-01
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 222
- Registration Number
- NCT01363648
- Locations
- 🇰🇷
Seoul National University Bundang, Seongnam, Gyeoinggido, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.